Breast Biopsy Market Information: By Technique Type (Biopsy Markers, Surgical Biopsy, MRI-guided Core Needle Biopsy), By Product (Biopsy Wires, Biopsy Needles), End-Users (Surgical and Diagnostic Centers)
Pune, India – June 19, 2019 —
A biopsy is a small operation that is used to perform the removal of tissues from an area of concern from the body.
Breast biopsy is a medical procedure that involves the testing of small samples of breast tissues for the detection of breast cancer.
The global Breast Biopsy Market is expected to expand in significant fashion during the forecast period of 2018 to 2023.
We specialize in performing breast surgery, breast biopsy and breast augmentation procedures in Texas.
Global breast biopsy devices market is forecasted to generate a revenue of $1.4 billion by 2023, P Market ResearchOn the basis of the procedure conducted for breast biopsy, the market is categorized into vacuum-assisted, core needle, fine needle aspiration, and surgical biopsy.
Vacuum-assisted biopsies have been accounting for the largest share in the breast biopsy devices market till now.
It is also expected to be the fastest growing category during the forecast period.
This can be mainly attributed to its various advantages, such as its ability to precisely locate the area of abnormality using imaging guidance, so that samples are removed only from the region of interest.Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/breast-biopsy-devices-market/report-sampleOn the basis of product, the breast biopsy devices market has been segmented into guidance systems, biopsy needles/guns, biopsy tables, biopsy wires, and other products.
Guidance systems are estimated to hold the largest share of 40.1%, in the market in 2017, with its demand majorly driven by the availability of stereotactic breast biopsy and tomosynthesis options in a single system, and the requirement of these systems in all types of surgeries.Globally, key players in the breast biopsy devices industry are launching products to gain a larger market share.
For instance, in November 2017, Siemens Healthineers, a subsidiary of Siemens AG, unveiled its new Mammomat Revelation imaging system at the 2017 Radiological Society of North America (RSNA) Annual Meeting in Chicago.